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Abstract
Background: The ankle blood pressure is commonly used as a ratio to the brachial blood
pressure, called ankle-brachial index (ABI). Very few studies have considered the independent value
of the ankle blood pressure without indexing it to the brachial blood pressure. We examined the
value of ankle blood pressure, together with the exercise blood pressure, as a predictor of
cardiovascular (CVD) and total mortality.
Methods: A prospective follow-up study of 3,858 consecutive ambulatory patients (mean age 51
years, 65,9% male) referred to a symptom-limited exercise test between August 1989 and
December 1995. The cohort was followed up for all-cause and CVD mortality until December 31,
2004, by record linkage with the National Causes-of-Death Register. The independent value of
ankle blood pressure as a predictor of cardiovascular and total mortality was assessed using Cox
proportional hazards modelling.
Results: The average follow-up time was 14 years, during which 346 persons died, 108 of them
due to CVD. Persons with normal (<140 mmHg) resting brachial blood pressure, ankle blood
pressure < 175 mmHg and exercise blood pressure at moderate exercise level ≤215 mmHg at
baseline investigation, had the best prognosis and were taken as the reference category. Among
persons with elevated ankle blood pressure (≥175 mmHg) but normal or borderline resting
brachial pressure and normal exercise blood pressure (≤215 mmHg) at moderate exercise level
the multivariate-adjusted hazard ratios (HR, 95% confidence interval) for CVD and total mortality
were 2.70 (1.52 – 4.80) and 2.13 (1.58 – 2.85), respectively. Similar and equally significant HRs were
observed in persons with both elevated ankle blood pressure and elevated exercise blood pressure,
as well as in those persons with elevated exercise blood pressure but ankle blood pressure < 175
mmHg.
Conclusion: These results suggest that the ankle blood pressure has an independent value as a
marker of arterial stiffness or subclinical atherosclerosis and a risk of future mortality in middle-
aged, asymptomatic persons.
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There are several established procedures for estimating
subclinical atherosclerotic changes in human arteries.
Increased carotid intima-media thickness is associated
with future cerebrovascular and cardiovascular events
[1,2]. Pulse wave velocity is related to arterial wall stiff-
ness, future hypertension and cardiovascular diseases
[3,4]. Coronary artery calcium screening is the latest
method for evaluating the CVD risk in asymptomatic
patients [5,6]. All these methods, however, require
sophisticated equipment and a specialized user. Accord-
ingly, they are not well suitable for the screening of early
arterial changes in a routine office practice and there is a
great need for a simple non-invasive tool that could be
used in an office setting to screen for arterial stiffness or
subclinical atherosclerosis.
The ankle blood pressure is usually measured in conjunc-
tion with the arm blood pressure and the ankle-brachial
pressure index (ABI) is calculated. Decreased index is
strongly associated with cardiovascular diseases [7-16].
Also elevated ABI value seems to be a significant risk factor
of CVD [17,18].
Patients with exaggerated exercise blood pressure reaction
have increased cardiovascular disease morbidity com-
pared with those with normal exercise blood pressure
reaction [19-22]. It is explained by increased sympathetic
tone and structural changes in arteries.
We hypothesized that in the beginning of the arterial stiff-
ening and atherosclerosis the ankle blood pressure may be
determined by local factors only, i.e., blood pressure and
the elastic properties of arteries. The elevated ankle blood
pressure might be one of the earliest signs of adverse
changes in the cardiovascular system. Stenotic changes
with abnormal ABI are fairly seldom seen in middle-aged
persons [13,14]. Ankle blood pressure ≤ 175 mmHg but
exaggerated elevation of brachial systolic blood pressure
at a moderate exercise level reveals those patients in
whom stenotic changes along the conduit vessels decrease
the ankle blood pressure and this group has to be consid-
ered as a separate entity.
Long-term prospective studies on the value of ankle blood
pressure in middle-age persons are currently sparse. There-
fore, the aim of the present study was to assess the inde-
pendent value of ankle blood pressure, together with the
brachial exercise blood pressure, as a predictor of cardio-




Subjects for this investigation were derived from a group
of 4,038 consecutive ambulatory patients, who under-
went symptom-limited bicycle exercise test at the Helsinki
Deaconess Institute between August 1989 and December
1995. The patients were referred by occupational health
physicians to a symptom-limited exercise test to rule out
coronary heart disease and evaluate physical fitness. More
precisely, 1,734 were sent for the evaluation of physical
fitness, 1,799 for diagnostic testing due to chest pain or
shortness of breath, 488 because of suspected arrhythmias
and 17 for mixed reasons, mainly for suspicion of exer-
cise-induced asthma. Patients with a history of myocardial
infarction, percutaneous coronary angioplasty, coronary
artery bypass grafting, congestive heart failure or stroke,
were excluded from the analysis. The final study group
consisted of 3,858 patients. The study was approved by
the Ethical Committee of the National Public Health
Institute.
Baseline vascular examination
Brachial blood pressure was measured by trained techni-
cians using the auscultatory method with a standard
sphygmomanometer from the left arm of the subject in a
supine position after a 5 minute rest. The ankle blood
pressure was simultaneously measured from the right leg
using a Doppler probe with a mercury sphygmomanome-
ter. If the pulse of the posterior tibial artery was absent, the
ankle blood pressure measurements were taken on the
dorsalis pedis artery.
Exercise ECG testing and measurement of exercise blood 
pressure
Exercise testing was conducted on an electronically braked
bicycle. The starting load was 50 Watts for men and 40
Watts for women, and the load was increased every 3 min-
utes by 50 Watts for men and 40 Watts for women. Blood
pressure was measured with a sphygmomanometer at 2
minutes at all loads and immediately prior to test termi-
nation. Readings were recorded to the nearest 5 mmHg.
The 2-minute blood pressure recording at the moderate
exercise level (150 W for men and 120 W for women) was
used in the analyses. If that level was not reached, blood
pressure from the lower level was used. The test was con-
tinued until a subject refused to continue, or until the
attending physician felt it unsafe to continue. The criteria
for myocardial ischaemia during the exercise test were
ischaemic changes in ECG defined as ST depression >1.0
mm at 60 ms after the J-point with typical ischaemic com-
plaints.
Other baseline characteristics
Other risk factors assessed at baseline were age, gender,
body mass index (BMI), smoking status, medical history,Page 2 of 9
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working capacity, self-reported history of cardiovascular
diseases, total cholesterol and glucose.
Blood pressure groups
Subjects were divided into five groups based on resting
ankle and exercise blood pressure at the moderate exercise
level (men 150 Watt, women 80 Watt): 1) Reference
group, where the resting ankle blood pressure was < 175
mmHg and the exercise blood pressure ≤ 215 mmHg; 2)
patients with elevated ankle blood pressure (≥175
mmHg) but normal exercise blood pressure (≤215
mmHg); 3) patients with elevated ankle (≥175 mmHg)
and elevated exercise blood pressure (>215 mmHg); 4)
elevated exercise blood pressure (>215 mmHg), but ankle
blood pressure <175 mmHg; and 5) patients who could
not be classified. Group 4 consists of patients with a dis-
crepancy between the ankle blood pressure and brachial
exercise systolic blood pressure, which indicated signifi-
cant stenotic changes along the conduit vessels. The
unclassifiable group could not reach the moderate exer-
cise level because of a specified reason (for example
ischaemic heart disease) or an unspecific reason (for
example poor physical fitness).
Follow-up procedures
The mortality follow-up data were available up to 15 years
(range 12 – 15 years) after the exercise test, until Decem-
ber 31st, 2004. Deaths were ascertained by record linkage
of the study data to the National Causes-of-Death Regis-
ter, on the basis of the personal identification code unique
to every resident of Finland. Thanks to the country-wide
register, the coverage of the follow-up was 100%.
In the Causes-of-Death Register deaths were coded accord-
ing to the Ninth (until Dec. 31st, 1995) and Tenth (since
the beginning of 1996) versions of the International Clas-
sification of Diseases (ICD). The primary endpoint was
cardiovascular death, and all-cause mortality was used as
a secondary endpoint. ICD-9 codes 410 to 414, 431, 436,
798, 4330A, 4331A, 3339A, 4341A, 4349A, 4376A or
ICD-10 codes I20–I25, I46, I61, I63–I64, R96, R98 as the
underlying cause of death were taken as cardiovascular
deaths. Altogether, 346 persons died during the follow-
up, 108 of the deaths were cardiovascular. As a whole, the
study consisted of 52,234 person-years of follow-up.
Statistical methods
Data are expressed as mean ± SD for continuous variables,
or counts and proportions for categorical variables. The
following cardiovascular risk factors were dichotomized:
early parental cardiovascular death (yes or no), self-
reported elevated cholesterol (>6 mmol/l, yes or no), self-
reported elevated blood glucose (>6 mmol/l, yes or no)
and current smoking (yes or no). Age, BMI, smoking
(years, packet/day) and blood pressure (mmHg) were
handled as continuous variables.
Continuous variables were compared between the blood
pressure groups with analysis of variance and proportions
with chi-square tests. Univariate associations between dif-
ferent blood pressure indicators were evaluated with Pear-
son's product-moment correlation coefficients.
Associations between the blood pressure groups and mor-
tality were analyzed using Kaplan-Meier survival curves
and log-rank tests. Cox proportional hazard models were
used for estimating the multivariate-adjusted independ-
ent associations of the blood pressure groups with total
and cardiovascular mortality. Results were expressed as
hazard ratios (HR) and 95% confidence intervals (CI)
compared to the reference group. The basic models were
adjusted for age and sex. The larger models were further
adjusted for BMI, physical working capacity (metabolic
equivalents = METs), self-reported blood glucose and cho-
lesterol, current smoking and early parental history of car-
diovascular disease. The statistical analyses were carried
out with R (Version 2.3.1).
Results
The mean age at baseline was 50.5 ± 10.0 years (range 15
– 84), and the mean BMI was 26.1 ± 3.8 kg/m2. The mean
brachial blood pressure was 133.1 ± 18.7/85.3 ± 10.9
mmHg) and pulse 73.8 ± 12.9/min. The correlation coef-
ficient between the brachial blood pressure at rest and the
exercise blood pressure at the moderate exercise level
(men 150 Watts, women 80 Watts) was 0.548 (n = 2,313,
P < 0.0001) in men and 0.649 (n = 1,211, P < 0.0001) in
women. The correlation coefficient between the ankle
blood pressure and systolic blood pressure at the moder-
ate exercise level was 0.543 (P < 0.0001) in men and
0.597 (P < 0.0001) in women.
Table 1 compares cardiovascular risk factors in different
blood pressure categories at baseline. The ABI differed sig-
nificantly between the groups being highest in groups 2
and 3 and lowest in groups 4 and 5. The reference group
(n = 2,203) was younger and leaner. In this group all risk
factors were more favourable compared with the other
groups. Myocardial ischaemia during exercise was diag-
nosed in 94 patients. The all-cause mortality during fol-
low-up was 89 patients (4.0%), 20 (0.9%) due to
cardiovascular causes.
In patients (n = 791) with elevated ankle blood pressure
(≥175 mmHg) and normal exercise blood pressure the
resting brachial blood pressure was normal or slightly ele-
vated: 144 ± 17/90 ± 10 mmHg. Of this group 36% were
on cardiovascular medication. In patients without any
medication (n = 510) the blood pressure was normal orPage 3 of 9
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whole group, 116 (14.7%) patients died during the fol-
low-up period, 37 (4.7%) due to cardiovascular causes.
Among patients (n = 509) with elevated ankle blood pres-
sure and elevated exercise blood pressure the male sex
dominated. The brachial blood pressure at rest was ele-
vated: 152.8 ± 17/94.0 ± 10 mmHg. Compared with the
previous group, BMI and ankle blood pressure were also
higher and the smoking history was longer. In patients
without any medication (n = 348) the mean blood pres-
sure at rest was elevated: 150.6 ± 16/93.1 ± 10 mmHg.
Myocardial ischaemia during exercise was diagnosed in 44
(8.6%) patients. The all-cause mortality in this group was
58 patients (11.4%) and the mortality due to cardiovascu-
lar disease was 20 patients (3.9%).
In patients with the discrepancy between the ankle blood
pressure and systolic blood pressure (group 4, n = 222)
there was no correlation between the ankle blood pressure
and exercise blood pressure at moderate level (r = 0.050,
n = 201, p = 0.49) among men and r = 0.059, n = 21, p =
0.80 among women). Compared with the reference group
the ankle blood pressure was a bit higher. The male sex
dominated (201/222) in this group, and smoking was
more common than in groups 1 and 2. Fifteen per cent
were on cardiovascular medication. Myocardial ischaemia
was diagnosed in 14 patients (6.3%), two of them died
during the follow-up. The all-cause mortality was 22
patients (9.9%) and the mortality due to cardiovascular
causes was 8 (3.6%).
The fifth group (n = 133) was older. They could not toler-
ate moderate exercise level because of ischaemic heart dis-
ease (n = 71) or leg atherosclerotic disease (ABI <0.97, n =
38). Abnormal lung function was observed in 10 patients
(oxygen <90%). Almost half of this group (45.2%) died
during the follow-up period, 23 (17.3%) due to cardio-
vascular causes. There were 43 patients with low fitness
without any specific reason. Twenty (47%) of them died
during the follow-up period, 6 (14%) due to cardiovascu-
lar causes. They tended to be current (n = 19) or ex-smok-
ers (n = 7). The male sex dominated (36/43). Nine were
on antihypertensive medication.
Figure 1 shows the Kaplan-Meier survival curves for cardi-
ovascular and all-cause mortality in different blood pres-
sure groups. For both endpoints the curves diverge
Table 1: Characteristics of the Study Participants by Ankle Blood Pressure (ABP) and Exercise Blood Pressure (EBP) Group.
Normal ABP 
Normal EBP
Elevated ABP and 
Normal EBP
Elevated ABP and 
Elevated EBP
Normal ABP and 
Elevated EBP
Unclassified
n = 2203 n = 791 n = 509 n = 222 n = 133 p
Age (years) 47 (10) 55 (9) 54 (7) 51 (9) 59 (10) 0.001*
Male/female 1419/820 447/358 435/87 205/21 105/30 0.001†
Body mass index (kg/m2) 25.4(4) 26.8 (4) 27.5 (4) 26.9 (4) 25.7 (4) 0.001*
Syst. BP (mmHg) 124 (14) 144 (17) 152 (17) 135 (16) 137 (20) 0.001*
Diast. BP (mmHg) 82 (9) 90 (10) 94 (10) 85 (9) 85 (11) 0.001*
Pulse/min 73 (13) 75 (13) 75 (13) 74 (13) 75 (14) 0.001*
SBP80 (women) 172 (20) 192 (15) 229 (11) 233 (13) - 0.001*
SBP150 (men) 186 (18) 199 (14) 236 (16) 231 (12) - 0.001*
SBPMax 193 203 240 236 178.3 0.001*
Ankle blood pressure (mmHg) 150 (17) 194 (14) 198 (18) 157 (14) 141 (37) 0.001*
ABI 1.21 (0.38) 1.31 (0.14) 1.27 (0.17) 1.16 (0.14) 1.03 (0.27) 0.001*
ABI < 0.97 n (%) 66 (3) 0 (0) 0 (0) 22 (1) 39 (29) 0.001†
Self-reported abnormal total cholesterol n 
(%)
925 (42) 340 (43) 234 (46) 122 (55) 74 (56) 0.001†
Self-reported abnormal glucose n (%) 132 (6) 95 (12) 66 (13) 27 (12) 35 (26) 0.001†
Pos. family history n (%) 793 (36) 324 (41) 188 (37) 95 (43) 69 (529 0.005†
Pack-years of smoking 9 (11) 9 (12) 13 (14) 14 (13) 20 (16) 0.001*
Current smokers n (%) 308 (14) 71 (9) 71 (14) 36 (16) 51 (38) 0.001†
METs 8.4 (3) 6.6 (2) 7.4 (2) 7.9 (1.9) 4.6 (1.5) 0.001*
Cardiovascular medication n (%) 22 (1) 285 (36) 178 (35) 33 (15) 60 (45) 0.001†
Diagnosed ischemic heart disease n (%) 88 (4) 142 (18) 46 (9) 13 (6) 72 (54) 0.001†
Deaths during follow-up n (%) 88 (4) 119 (15) 56 (11) 22 (10) 60 (45) 0.001†
Cardiovascular deaths during follow-up n 
(%)
20 (0.9) 40 (5) 20 (4) 9 (4) 23 (17) 0.001†
Mean values (S.D.) or proportions (%), * ANOVA, † χ2 test
SBP80 = systolic blood pressure at the exercise level of 80 Watts
SBP150 = systolic blood pressure at the exercise level of 150 Watts
SBPMax = maximum systolic blood pressure during exercise
ABI = Ankle Brachial Index
METs = Exercise capacity measured in metabolic equivalentsPage 4 of 9
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Cardiovascular and all-cause mortality by the blood pressure groupFigure 1
Cardiovascular and all-cause mortality by the blood pressure group. Kaplan-Meier survival curves for cardiovascular 
and all-cause mortality. Log-rank test for the survival difference between the blood pressure groups: p < 0.0001 for cardiovas-
cular mortality and p < 0.0001 for all-cause mortality. The numbers indicate people remaining in the follow-up at different 
points in time. All participants were not followed up for 200 months. The reference group consists of patients with normal bra-
chial blood pressure (< 140 mmHg), ankle blood pressure <175 mmHg and exercise blood pressure ≤215 mmHg at the mod-
erate exercise level. Group 2 had elevated ankle blood pressure (≥175 mmHg) but normal exercise blood pressure. Group 3 
had elevated ankle and exercise blood pressure. Group 4 had ankle blood pressure < 175 mmHg but elevated exercise blood 




Reference Group N = 2203 2193 2166 1708  149 
 Group 2 N = 791   772   747   516      42 
 Group 3 N = 509  496   484   306      14 
 Group 4 N = 222   219   213   160       14 
 Group 5 N = 133   122   105     14    7 
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follow-up.
Compared with group 1, the age and sex-adjusted hazard
ratios of CVD and all-cause mortality were significantly
elevated in all other groups (Table 2). Further adjustment
for traditional risk factors, such as smoking, BMI, parental
history of early CVD, self-reported elevated cholesterol
and blood glucose attenuated the HRs slightly, but they
nevertheless remained clearly significant.
For comparison, we calculated the HRs for the different
levels of ankle blood pressure alone (Table 3). Patients
with abnormal ABI (<0.97) were kept as their own group.
The age and gender adjusted HRs increased linearly with
higher ankle blood pressure and were highest in patients
with abnormal ABI. Multivariate-adjusted HRs behaved
similarly, although they reached statistical significance for
all-cause mortality only. Moreover, we calculated the HRs
for the usual resting brachial systolic blood pressure,
dichotomized at 160 mmHg (<160 mmHg vs ≥160
mmHg). In the age and sex-adjusted model, the HR for
CVD death was 1.94 (1.23 – 3.06, p = 0.004). In the larger
model the HR was attenuated to 1.6 (1.01 – 2.54, p =
0.04).
Discussion
In the present study, we demonstrated that the ankle
blood pressure gives us important information about the
status of the arterial tree in middle-aged asymptomatic
individuals. The main finding was that even those persons
among whom the elevated ankle blood pressure was the
only abnormal finding had 2.7-fold higher multivariate-
adjusted risk of CDV death and 2.1-fold higher risk of
death from any cause than persons with normal brachial,
ankle and exercise blood pressures. This suggests that the
measurement of ankle blood pressure could be a relatively
simple, inexpensive and non-invasive tool for assessing
early, subclinical atherosclerotic changes in young and
middle-aged individuals. This finding is consistent with
earlier studies suggesting a J-shaped association between
ABI and CVD risk [5,17,18].
At least three independent lower-extremity large-vessel
characteristics determine the ankle blood pressure: local
pressure, elasticity of the vessels and the pulse wave. Arte-
rial stiffness with increased pulse wave velocity and aug-
mented pulse pressure cause a strong cyclic stretching on
vascular smooth muscle cells [23-26]. Hypertrophy and
structural changes decrease the elasticity of the conduit
vessels, and elevated ankle blood pressure is measured. An
unanswered question is, when is the ankle blood pressure
determined only by local factors, and when do stenotic
changes along the conduit vessels begin to have an effect
on the peripheral ankle blood pressure. We postulate that
this stage is reached when the exercise causes an exagger-
ated blood pressure reaction but the ankle blood pressure
is within the normal limits.
Although the importance of exercise hypertension
remains controversial, the majority of recent studies show
that an exaggerated systolic blood pressure response to
exercise is an independent predictor of future hyperten-
sion and CVD mortality [18-20,26-29]. It is associated
Table 2: Hazard Ratios (HR, 95% Confidence Interval (CI)) of Cardiovascular and All-Cause Deaths According to Specified Blood 
Pressure Groups.
Model 1 Model 2
HR 95% CI p HR 95% CI p
Cardiovascular death
Group 1 1 (reference) 1 (reference)
Group 2 3.11 1.79 – 5.41 < 0.0001 2.62 1.49 – 4.62 0.0003
Group 3 2.77 1.48 – 5.16 0.003 2.48 1.33 – 6.62 0.003
Group 4 2.78 1.22 – 6.33 0.02 2.36 1.04 – 5.37 0.02
Group 5 8.45 4.42 – 16.15 <0.0001 4.28 2.07 – 8.87 <0.0001
All-cause death
Group 1 1 (reference) 1 (reference)
Group 2 2.40 1.81 – 3.20 <0.0001 2.13 1.59 – 2.85 < 0.0001
Group 3 2.01 1.43 – 2.81 <0.0001 1.80 1.29 – 2.53 <0.0001
Group 4 1.98 1.25 – 3.15 0.003 1.70 1.07 – 2.70 0.03
Group 5 5.92 4.15 – 8.46 <0.0001 3.21 2.15 – 4.79 <0.0001
Model 1: adjusted for age and sex
Model 2: adjusted for age, sex, BMI, smoking, early parental cardiovascular disease, exercise capacity measured in metabolic equivalents, self-
reported elevated cholesterol and abnormal blood glucose
Please see Table 1 and the Methods-section for the explanation for the blood pressure groupsPage 6 of 9
(page number not for citation purposes)
BMC Cardiovascular Disorders 2008, 8:3 http://www.biomedcentral.com/1471-2261/8/3with insulin resistance [30], hypercholesterolemia [31],
carotid atherosclerosis [22] and other target-organ dam-
age [32]. The pathophysiology of exaggerated blood pres-
sure response is not yet fully understood. Two processes
have been involved in most studies: increased sympa-
thetic tone and structural changes in the vessels.
The categorization of our study cohort into five subgroups
enabled a logical understanding of the chronological
sequence of adverse changes in the ankle blood pressure.
In patients with normal ankle, arm and exercise blood
pressure, both CVD and total mortality during the follow-
up were low even among persons with an abnormal exer-
cise test. The elevated ankle blood pressure either with or
without elevated exercise blood pressure was significantly
associated with CVD mortality and all-cause mortality. It
is associated with abnormally high ABI, which has also
been found in other studies [17,18].
Patients with elevated exercise blood pressure but ankle
blood pressure ≥175 mmHg are a more discrete group.
With our cut-points (ankle blood pressure ≥175 mmHg
and exercise blood pressure at moderate exercise level >
215 mmHg) they formed a group in which CVD and all-
cause mortality were at the same level as in patients with
elevated ankle blood pressure. The discrepancy between
the ankle and exercise blood pressures can be explained
by hemodynamically significant stenotic changes along
the conduit vessels. The poor correlation between the
exercise brachial blood pressure and the ankle blood pres-
sure is in accordance with the existence of stenotic
changes. Also, abnormally low ABI was observed in group
4 compared with the reference group.
Normally there is a strong correlation between the arm,
ankle and exercise blood pressures as long as the stenotic
changes along the conduit vessels are minor. Similar cor-
relation between the systolic blood pressure and maximal
or submaximal exercise blood pressure has been found in
other studies [27]. Elevated ankle blood pressure alone is
also associated with an increased risk for CVD- and overall
mortality. Exercise test reveals further those patients,
where changes in the conduit vessels decrease the ankle
blood pressure and the healthy reference group becomes
more accurately defined.
Low cardiovascular fitness is associated with premature
mortality. The literature is filled with long-term follow-up
studies, conducted in relatively healthy populations [33-
36], or focused on clinical patient populations [36],
which have indicated, that exercise capacity is a more
powerful predictor of mortality than the other established
risk factors. One third of our unclassifiable group died
during the follow-up and most of them belonged to the
group with low physical fitness without any specific rea-
son.
Our study has certain limitations. The patients were
referred by occupational health physicians and thus they
do not represent a random sample of the general popula-
tion. The reference group is a predominantly well-edu-
cated group. The ankle blood pressure was measured from
Table 3: Hazard Ratios (HR, 95% Confidence Interval (CI) of Cardiovascular and All-Cause Deaths in Different Levels of Ankle Blood 
Pressure (ABP).1
Model 1 Model 2
Ankle Blood Pressure Category (n) HR 95% CI p HR 95% CI p
Cardiovascular death
100–150 mmHg (n = 1214) 1 (reference) 1 (reference)
151–174 mmHg (n = 1082) 1.54 0.85 – 2.79 0.2 1.52 0.83 – 2.78 0.2
175–200 mmHg (n = 1086) 1.71 0.97 – 3.02 0.06 1.73 0.97 – 3.07 0.06
201–300 mmHg (n = 355) 1.98 1.03 – 3.84 0.04 1.77 0.91 – 3.45 0.1
Abnormal (< 0.97) ABI (n = 121) 2.38 1.10 – 5.17 0.03 1.53 0.68 – 3.4 0.3
All-cause death
100–150 mmHg (n = 1214) 1 (reference) 1 (reference)
151–174 mmHg (n = 1082) 1.30 0.95 – 1.79 0.1 1.30 0.94 – 1.79 0.2
175–200 mmHg (n = 1086) 1.44 1.06 – 1.95 0.02 1.47 1.08 – 2.00 0.02
201–300 mmHg (n = 335) 1.70 1.18 – 2.43 0.003 1.53 1.06 – 2.21 0.02
Abnormal (0.97)
ABI (n = 121)
2.20 1.43 – 3.40 < 0.0001 1.49 1.00 – 2.33 0.02
Model 1: adjusted for age and sex
Model 2: adjusted for age, sex, BMI, smoking, early parental cardiovascular disease, exercise capacity measured in metabolic equivalents, self-
reported elevated cholesterol and abnormal blood glucose
Please see Table 1 and the Methods-section for the explanation for the blood pressure groups
1 Persons with low ABI separated as their own groupPage 7 of 9
(page number not for citation purposes)
BMC Cardiovascular Disorders 2008, 8:3 http://www.biomedcentral.com/1471-2261/8/3one leg only. The blood glucose and total cholesterol were
self-reported and only half of the patients knew their glu-
cose value. However, our purpose was not to explain the
aetiology of elevated ankle blood pressure but to examine
its prognostic value. These limitations of our study should
not affect the validity of the findings. Furthermore, most
patients with a diagnosed MI during the follow-up had
received pharmacological therapy or undergone invasive
therapeutic procedures and their lifestyle had changed.
Such a bias has probably led to an underestimation, rather
than an overestimation, of the prognostic significance of
elevated ankle blood pressure.
Conclusion
In the present study we showed that the ankle blood pres-
sure – without indexing to arm blood pressure – has an
independent value as a marker of subclinical atherosclero-
sis in asymptomatic middle-aged patients. The elevated
ankle blood pressure is one of the earliest sign of the
adverse changes in the arteries. It identifies high-risk indi-
viduals and may provide the necessary motivation to pro-
mote lifestyle changes. On the other hand, exaggerated
exercise blood pressure reaction with normal ankle blood
pressure reveals those patients with stenotic changes
along the conduit vessels. They are likely to need more
detailed investigations and intensive therapy. Thus, meas-
urement of the ankle blood pressure could be an inexpen-
sive and non-invasive tool which helps to assess the CVD
risk and to guide the intensity of other examinations and
therapies.
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